EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

A systematic review of dengue controlled human infection studies: safety, viral kinetics and immunology

Srishti Chhabra iD, Po Ying Chia, Yee-Sin Leo, Barnaby Edward Young

PLOS Neglected Tropical Diseases · 12.03.2026 · 20 (3) · e0014086

DOI: 10.1371/journal.pntd.0014086 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 12.03.2026. Verfasst von Srishti Chhabra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore, Singapore. Hauptthemen laut MEDLINE: Dengue, Dengue Virus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, Human Infection Challenge Vaccine (HIC-Vac) Development Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The immunopathogenesis of dengue infection and immune correlates of protection are uncertain, no therapeutic anti-viral is available, and the long-term risks of severe breakthrough infection after vaccination remain of concern. Dengue controlled human infection models (DCHIM) have found increasing utility and have the potential to address these unmet needs. We reviewed the clinical, biochemical and immunologic features of modern day DCHIMs.

Methods

A systematic review protocol was developed and registered with PROSPERO [CRD42024558534]. We searched MEDLINE, Cochrane and Embase for controlled human infection studies using attenuated dengue virus strains from January 2000 – December 2025. No restriction was placed on study setting (dengue endemic/non-endemic) or whether the study was conducted in seronegative or seropositive individuals. The primary outcome was the proportion of inoculated participants who developed viraemia (‘attack rate’).

Results

Our search yielded 1181 results, and identified 11 published studies, recruiting 248 participants aged 18–55 years. All studies were performed in non-dengue endemic areas and were models of primary dengue. Four studies challenged previously vaccinated individuals, and one utilised DCHIM to assess antiviral efficacy. Attenuated dengue virus strains of all four DENV 1–4 serotypes were utilised as challenge agents. Attack rate across all serotypes was 50–100% in seronegative participants and 0–83% in previously vaccinated participants and was strain-dependent. Clinical and biochemical features of dengue fever varied between strains, with peak viral load and probability of fever being highly correlated (r = 0·91, p < 0·01). There were no serious adverse event reported, and 9 (4%) participants met protocol criteria for hospitalisation. Viral and/or immune evidence of disease enhancement was observed in 5/81 (7%) of challenged seropositive participants.

Conclusion

DCHIMs of primary dengue are a valuable and safe tool that has supported vaccine development. Further work is needed to expand DCHIMs to endemic settings and as a model of secondary dengue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueDengue VirusHumansHuman Challenge Trials as TopicAdultAdolescentDengue VaccinesMiddle AgedYoung AdultViremiaViral Load

Substanzen

Dengue Vaccines

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore, Singapore.
  • National Centre for Infectious Diseases, Singapore, Singapore.
  • Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

ORCID-Profile: Srishti Chhabra

Förderung

  • National Medical Research Council
  • Human Infection Challenge Vaccine (HIC-Vac) Development Network

Zitieren

APA

Chhabra, S., Chia, P. Y., Leo, Y. S., & Young, B. E. (2026). A systematic review of dengue controlled human infection studies: safety, viral kinetics and immunology. PLOS Neglected Tropical Diseases, 20(3), e0014086. https://doi.org/10.1371/journal.pntd.0014086

Vancouver

Chhabra S, Chia PY, Leo YS, Young BE. A systematic review of dengue controlled human infection studies: safety, viral kinetics and immunology. PLOS Neglected Tropical Diseases. 2026;20(3):e0014086. doi:10.1371/journal.pntd.0014086

BibTeX
@article{Chhabra2026,
  author = {Chhabra, Srishti and Chia, Po Ying and Leo, Yee-Sin and Young, Barnaby Edward},
  title = {A systematic review of dengue controlled human infection studies: safety, viral kinetics and immunology},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {e0014086},
  doi = {10.1371/journal.pntd.0014086}
}
Kostenlos starten →